The purpose of the present study was to gather qualitative information from parents and children with type 1 diabetes about their experiences of participation in an ongoing randomized study (multiple daily injection [MDI] vs. continuous subcutaneous insulin infusion [CSII]) in which recruitment took place immediately after diagnosis. The gene discussed is INS; the disease is type 1 diabetes mellitus.